Iterum Therapeutics
Price & Volume
Stats
See more52W Range | $0.80-$2.50 |
Market Cap | $49.8M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $37,000 |
Diluted EPS | -$1.76 |
News
See moreYahoo Finance • last year
Iterum Therapeutics Reports Third Quarter 2023 Financial Results
Yahoo Finance • last year
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023
Yahoo Finance • last year
Iterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
Yahoo Finance • last year
Iterum Therapeutics to Present Data at IDWeek 2023
About
CEO | Mr. Corey N. Fishman |
Address | Fitzwilliam Court, Dublin, Ireland, D02 YW24 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
